Literature DB >> 8599954

Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease.

J C Alonso1, F J Lopez-Longo, J L Lampreave, C M González, O Vegazo, L Carreño, I Almoguera.   

Abstract

Abdominal scintigraphy with technetium-99m hexamethylpropylene amine oxime (99mTc-HMPAO)-labelled leucocytes is an excellent tool for evaluating disease extent and activity of intestinal lesions in patients with inflammatory bowel disease (IBD). In some cases of seronegative spondylarthropathies (SSp), IBD may remain subclinical. The aim of this study was to evaluate the presence of positive abdominal scintigraphy in patients with SSp and without clinical symptoms or signs of IBD. To this end we studied 32 patients with active SSp (European Spondylarthropathy Study Group 1991 criteria) without clinical evidence of IBD (eight had ankylosing spondylitis, four psoriatic arthritis, three reactive arthritis an 17 undifferentiated SSp) and 11 controls without SSp. All SSp and control patients received similar doses of non-steroidal anti-inflammatory drugs (NSAIDs). Abdominal scintigraphic images were obtained at 30 and 120 min after re-injection of 99mTc-HMPAO-labelled leucocytes. The 99mTc-HMPAO-labelled leucocyte scan was positive in 17 patients with SSp (53.1%) (six with ankylosing spondylitis, three with psoriatic arthritis, two with reactive arthritis and six with undifferentiated SSp). Fourteen patients scored from 2 to 4 on the intensity of uptake scale. The colon and terminal ileum were predominantly involved. Axial involvement was more frequent in patients with a positive scan than in patients with negative results (P<0.05) (64.7% vs 26.6%; odds ratio: 5). No control patient showed a positive scan. It is concluded that 99mTc-HMPAO-labelled leucocyte scan shows increased uptake among patients with SSp without evidence of IBD. These findings provide new evidence linking SSp with intestinal inflammation and suggest that in some cases a bowel-related process could contribute to the development of SSp. Long-term follow-up studies with more patients are necessary to evaluate the diagnostic and therapeutic implications of these results.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8599954     DOI: 10.1007/bf00837621

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  15 in total

1.  Technetium-99m hexamethyl propylene amine oxine leucocytes in the assessment of disease activity in inflammatory bowel disease.

Authors:  E Lantto; K Järvi; I Krekelä; T Lantto; M Taavitsainen; H Vedenkangas; M Vorne
Journal:  Eur J Nucl Med       Date:  1992

2.  Ileocolonoscopy in seronegative spondylarthropathy.

Authors:  M De Vos; C Cuvelier; H Mielants; E Veys; F Barbier; A Elewaut
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

3.  Intestinal Clostridium perfringens in rheumatoid arthritis and other collagen diseases.

Authors:  B Olhagen; I Månsson
Journal:  Acta Med Scand       Date:  1968-11

4.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

5.  The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy.

Authors:  M Dougados; S van der Linden; R Juhlin; B Huitfeldt; B Amor; A Calin; A Cats; B Dijkmans; I Olivieri; G Pasero
Journal:  Arthritis Rheum       Date:  1991-10

6.  Gut inflammation in the spondyloarthropathies: clinical, radiologic, biologic and genetic features in relation to the type of histology. A prospective study.

Authors:  H Mielants; E M Veys; S Goemaere; K Goethals; C Cuvelier; M De Vos
Journal:  J Rheumatol       Date:  1991-10       Impact factor: 4.666

7.  Scintigraphic assessment of bowel involvement and disease activity in Crohn's disease using technetium 99m-hexamethyl propylene amine oxine as leukocyte label.

Authors:  J Schölmerich; E Schmidt; C Schümichen; P Billmann; H Schmidt; W Gerok
Journal:  Gastroenterology       Date:  1988-11       Impact factor: 22.682

8.  Fast diagnosis of abdominal infections and inflammations with technetium-99m-HMPAO labeled leukocytes.

Authors:  E H Lantto; T J Lantto; M Vorne
Journal:  J Nucl Med       Date:  1991-11       Impact factor: 10.057

9.  Technetium-99m HM-PAO-labeled leukocytes in detection of inflammatory lesions: comparison with gallium-67 citrate.

Authors:  M Vorne; I Soini; T Lantto; S Paakkinen
Journal:  J Nucl Med       Date:  1989-08       Impact factor: 10.057

10.  Late onset pauciarticular juvenile chronic arthritis: relation to gut inflammation.

Authors:  H Mielants; E M Veys; R Joos; C Cuvelier; M De Vos; F Proot
Journal:  J Rheumatol       Date:  1987-06       Impact factor: 4.666

View more
  2 in total

Review 1.  Role of scintigraphy in inflammatory bowel disease.

Authors:  Maria I Stathaki; Sophia I Koukouraki; Nikolaos S Karkavitsas; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

2.  Tc-99m HIG Scintigraphy in Detection of Active Inflammation in Ankylosing Spondylitis.

Authors:  Ozhan Ozdoğan; Berna Değirmenci; Ozlem Senocak; Selmin Gülbahar; Gülhan Arslan; Cengiz Taşçı; Elif Akalın; Hatice Durak
Journal:  Mol Imaging Radionucl Ther       Date:  2011-08-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.